Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Phys Rev Lett ; 124(1): 010404, 2020 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-31976727

RESUMEN

One-dimensional polar gases in deep optical lattices present a severely constrained dynamics due to the interplay between dipolar interactions, energy conservation, and finite bandwidth. The appearance of dynamically bound nearest-neighbor dimers enhances the role of the 1/r^{3} dipolar tail, resulting in the absence of external disorder, in quasi-localization via dimer clustering for very low densities and moderate dipole strengths. Furthermore, even weak dipoles allow for the formation of self-bound superfluid lattice droplets with a finite doping of mobile, but confined, holons. Our results, which can be extrapolated to other power-law interactions, are directly relevant for current and future lattice experiments with magnetic atoms and polar molecules.

2.
Vet Comp Oncol ; 16(4): 511-517, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29961972

RESUMEN

Mast cell tumours (MCTs) are often diagnosed by cytology based on the identification of purple intracytoplasmic granules with methanolic Romanowsky stains, including May-Grünwald-Giemsa (MGG). In clinical practice, aqueous rapid stains (RS) are commonly used, but mast cell granules may not stain properly. Aim of this prospective study was to investigate the frequency of MCT hypogranularity with RS and its potential implications in tumour identification, cytological grading assessment and recognition of nodal metastatic disease. Cytological preparations of canine primary MCTs and metastatic lymph nodes with subsequent histopathological confirmation were included. For each case, good-quality smears were stained with both MGG and RS and comparatively assessed. Eleven of 60 (18.3%) primary MCTs were hypogranular with RS; 9 of them were histologically high-grade tumours and in 3 cases (5%) a definitive MCT diagnosis could not be made. Accuracy in cytological grading assessment (85%) did not differ between RS and MGG. Thirteen of 28 (46.4%) metastatic lymph nodes were hypogranular with RS and 3 independent observers failed to identify nodal MCT metastases in 7% to 18% of RS-stained smears. This study confirms that, in limited cases, RS can be ineffective in staining MCT granules, particularly in high-grade tumours, thus making diagnosis more dependent on experience and quality of preparations. In dubious cases, methanolic stains should be applied. The use of RS is discouraged for the search of nodal metastases, as the identification of isolated mast cells can be more challenging.


Asunto(s)
Colorantes/uso terapéutico , Enfermedades de los Perros/diagnóstico , Eosina Amarillenta-(YS)/uso terapéutico , Mastocitosis/veterinaria , Azul de Metileno/uso terapéutico , Animales , Biopsia con Aguja Fina/veterinaria , Enfermedades de los Perros/patología , Perros , Mastocitos/patología , Mastocitosis/diagnóstico , Mastocitosis/patología , Mastocitosis Cutánea/diagnóstico , Mastocitosis Cutánea/patología , Mastocitosis Cutánea/veterinaria , Mastocitosis Sistémica/diagnóstico , Mastocitosis Sistémica/patología , Mastocitosis Sistémica/veterinaria , Pronóstico , Estudios Prospectivos
3.
Maturitas ; 54(3): 222-8, 2006 Jun 20.
Artículo en Inglés | MEDLINE | ID: mdl-16343828

RESUMEN

OBJECTIVES: Sex steroid hormones are implicated in the cognitive processes of the adult brain. Among studies reporting a positive effect of estrogen replacement therapy (ERT) on cognition, the most consistent evidence is that it enhances verbal memory and visuospatial functions. In the present study we investigated the effect of ERT on cognition and on brain morphology in healthy postmenopausal women, taking into account the distinction in current and past ERT users. METHODS: Participants were postmenopausal nondemented women recruited from the community: ERT users were 40 (23 current users, 17 past users), while never users were 43. Forty of recruited subjects gave consent to undergo 3D high resolution MRI (16 current users, 7 past users and 17 never users). Participants underwent MMSE and a battery of neuropsychological tests measuring memory, language, intelligence, attention and visuo-spatial abilities. RESULTS: The past users group outperformed the never users in four tests: Token test, WCST categories, attentional matrices and Rey's delayed list; the current users group outperformed the never users in the Rey's list test. ERT users had greater grey matter volumes mainly in the cerebellum, but an increase was observed also in the parietal and occipital cortex. CONCLUSIONS: ERT use appears to improve linguistic, attentive and planning abilities. Interestingly, the beneficial effects on cognition were detected mainly in the past users subgroup. Here we propose that the trophic effect of estrogens on cerebellum might account for the observed improvement in cognition.


Asunto(s)
Cognición , Terapia de Reemplazo de Estrógeno , Estudios de Casos y Controles , Cerebelo/efectos de los fármacos , Femenino , Humanos , Persona de Mediana Edad , Pruebas Neuropsicológicas , Posmenopausia
4.
Curr Alzheimer Res ; 1(3): 215-8, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15975068

RESUMEN

Genetic factors are involved in the aetiology of dementias. Three genes have been identified which, when mutated, cause Familial Alzheimer disease (FAD): the presenilin-1 (PS1), the presenilin-2 (PS2) and the amyloid precursor protein (APP) genes. Together, these mutations are responsible for 30-50% of the cases with autosomal dominant Alzheimer disease (AD), and for about 5% of all AD cases. While over 130 mutations have been identified in PS1, mutations in PS2 and APP are rarer, since only 10 and 22 mutations, respectively, have been found in these FAD genes. Instead, mutations in the MAPT gene were associated with Familial Frontotemporal dementia (FFTD) linked to chromosome 17 (FTDP-17). Frontotemporal dementia (FTD) can occur in a sporadic form, but in 30-50% of cases there is a positive family history of dementia. In this study, we determined the spectrum of mutations and the relative contribution of the above mentioned four genes in our Italian clinical series of patients with a positive family history of dementia.


Asunto(s)
Precursor de Proteína beta-Amiloide/genética , Demencia/genética , Frecuencia de los Genes , Proteínas de la Membrana/genética , Mutación , Proteínas del Tejido Nervioso/genética , Anciano , Enfermedad de Alzheimer/genética , Secuencia de Bases , Mapeo Cromosómico , Cromosomas Humanos Par 17 , Femenino , Humanos , Italia , Masculino , Persona de Mediana Edad , Presenilina-1 , Presenilina-2 , Proteínas tau
5.
J Neural Transm (Vienna) ; 110(9): 1029-39, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12938025

RESUMEN

Defects in energy metabolism and oxidative stress play an important role in the pathogenesis of Alzheimer's Disease (AD). In sporadic AD cases, presenilin 2 (PS2) mRNA levels are decreased in brain areas affected by the disease. The aim of the present study was to investigate whether mitochondrial dysfunction might influence PS2 gene expression. We demonstrated that the inhibition of energy metabolism by sodium azide down-regulates PS2 gene expression through modification of promoter activity. No one of the analyzed transcription factors, sensitive to redox status of the cell, could explain this effect. Azide effect on PS2 expression was completely inhibited by the addition of an antioxidant suggesting that the imbalance of the cellular redox homeostasis modulates the expression of this gene.


Asunto(s)
Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/metabolismo , Encéfalo/metabolismo , Metabolismo Energético/genética , Proteínas de la Membrana/genética , Mitocondrias/metabolismo , Antioxidantes/farmacología , Encéfalo/fisiopatología , Línea Celular Tumoral , Regulación hacia Abajo/efectos de los fármacos , Regulación hacia Abajo/genética , Metabolismo Energético/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/fisiología , Humanos , Oxidación-Reducción/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/genética , Presenilina-2 , Regiones Promotoras Genéticas/genética , ARN Mensajero/metabolismo , Azida Sódica/farmacología , Factores de Transcripción/efectos de los fármacos , Factores de Transcripción/fisiología
6.
Exp Neurol ; 182(2): 335-45, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12895444

RESUMEN

Brain deposition of the amyloid-beta protein (Abeta) is a frequent complication of Down's syndrome (DS) patients. Abeta peptide is generated by endoproteolytic processing of Abeta precursor protein by gamma and beta secretases. Recently a transmembrane aspartyl protease, BACE, has been identified as the beta-secretase, and its homologous BACE-2 has also been described. BACE-2 gene resides on chromosome 21 in the obligate DS region. It cleaves Abeta precursor protein at its beta site and more efficiently at a different site within Abeta. In the present study we characterized the BACE-2 gene and protein expression in the DS patients and healthy control. We analyzed, by using a nonradioactive ribonuclease protection assay, the levels of BACE-2 mRNA expression in primary skin fibroblasts. The analysis revealed a 2.6-fold increase in BACE-2 mRNA levels in the DS group compared to the levels observed in the control group. Western blot analysis revealed no difference between DS and control in BACE-2 protein levels in the intracellular compartment. In the medium conditioned by fibroblast, we revealed an evident secretion of BACE-2 protein, represented by two different molecular weights, remarkably increased in DS fibroblasts. BACE-2 overexpression was also confirmed in the DS fetal brains and human neural embryonic DS stem cells in which conditioned media BACE-2 was secreted. These data highlight the importance of the extracellular compartment where BACE-2 overexpression could play a role in plaque formation in DS patients.


Asunto(s)
Ácido Aspártico Endopeptidasas/biosíntesis , Encéfalo/enzimología , Síndrome de Down/enzimología , Fibroblastos/enzimología , Células Madre/enzimología , Adulto , Secretasas de la Proteína Precursora del Amiloide , Ácido Aspártico Endopeptidasas/genética , Ácido Aspártico Endopeptidasas/metabolismo , Western Blotting , Encéfalo/embriología , Química Encefálica , Células Cultivadas , Medios de Cultivo Condicionados/química , Fibroblastos/citología , Fibroblastos/metabolismo , Humanos , Peso Molecular , Neuronas/citología , Neuronas/enzimología , ARN Mensajero/análisis , ARN Mensajero/biosíntesis , Valores de Referencia , Células Madre/citología , Células Madre/metabolismo
7.
Exp Cell Res ; 269(2): 256-65, 2001 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-11570818

RESUMEN

Mutations in gene encoding presenilin 1 (PS1) are responsible for the majority of familial Alzheimer's disease (FAD) cases. We studied PS1 localization in HEK293 cells and in primary neurons obtained from rat cortex and hippocampus. We first demonstrated that PS1-CTF, but neither PS1-FL nor PS1-NTF, is released into the medium as a soluble and membrane-associated form. After induction of apoptosis with staurosporine (Sts), we observed a dramatic increase in the level of PS1-CTF in the medium, both in HEK293 and in primary neurons. Immunocytochemical analysis suggested that the release of PS1-CTF might occur via membrane shedding. Abeta(1-42) treatment reduced PS1-CTF extracellular levels. This decrease was strongly associated to an impaired secretion of sAPP fragments, thus suggesting a role of PS1-CTF in the control of trafficking and generation of APP fragments.


Asunto(s)
Proteínas de la Membrana/química , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/farmacología , Animales , Apoptosis , Western Blotting , Línea Celular , Células Cultivadas , Corteza Cerebral/metabolismo , Inhibidores Enzimáticos/farmacología , Matriz Extracelular/metabolismo , Hipocampo/metabolismo , Humanos , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Microscopía Fluorescente , Neuronas/metabolismo , Fragmentos de Péptidos/farmacología , Péptidos/farmacología , Presenilina-1 , Unión Proteica , Estructura Terciaria de Proteína , Ratas , Ratas Wistar , Estaurosporina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...